The retrospective analysis of dogs bearing pulmonary metastatic oral malignant melanoma suggested that the use of previous (≤8 weeks) hypofractionated radiation therapy is associated with a better clinical response to anti-PD-L1 immunotherapy. The gene discussed is CD274; the disease is melanoma.